DanaherDHR
About: In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Employees: 63,000
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
76% more call options, than puts
Call options by funds: $1.78B | Put options by funds: $1.01B
28% more first-time investments, than exits
New positions opened: 250 | Existing positions closed: 196
1.38% more ownership
Funds ownership: 77.6% [Q3] → 78.99% (+1.38%) [Q4]
1% more funds holding
Funds holding: 2,242 [Q3] → 2,262 (+20) [Q4]
16% less capital invested
Capital invested by funds: $156B [Q3] → $131B (-$24.6B) [Q4]
18% less repeat investments, than reductions
Existing positions increased: 766 | Existing positions reduced: 933
42% less funds holding in top 10
Funds holding in top 10: 97 [Q3] → 56 (-41) [Q4]
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
9 analyst ratings
RBC Capital Conor McNamara 15% 1-year accuracy 6 / 41 met price target | 31%upside $250 | Outperform Reiterated | 23 Apr 2025 |
Goldman Sachs Matthew Sykes 43% 1-year accuracy 15 / 35 met price target | 26%upside $240 | Buy Maintained | 23 Apr 2025 |
Guggenheim Subbu Nambi 39% 1-year accuracy 9 / 23 met price target | 31%upside $250 | Buy Reiterated | 23 Apr 2025 |
UBS Dan Leonard 62% 1-year accuracy 8 / 13 met price target | 26%upside $240 | Buy Maintained | 23 Apr 2025 |
Baird Catherine Schulte 22% 1-year accuracy 4 / 18 met price target | 18%upside $225 | Outperform Maintained | 23 Apr 2025 |
Financial journalist opinion
Based on 19 articles about DHR published over the past 30 days









